We compared TLR responsiveness in PBMC from HIV-1-infected and uninfected individuals
using the TLR agonists: TLR7 (3M-001), TLR8 (3M-002), and TLR7/8 (3M-011). Activation …

The aim of this study was to compare the short‐term and long‐term efficacy and safety of
lymphoblastoid interferon with a recombinant interferon alfa (IFN‐α) in a 24‐week treatment …

During prolonged recombinant interferon (rIFN)‐α2 therapy, a minority of patients develop
high‐titer neutralizing IFN‐α antibodies. Sera from nine IFN‐α antibody‐positive patients …

A pronounced genetic polymorphism of the interferon type I gene family has been assumed
on the basis of RFLP analysis of the genomic region as well as the large number of …

Chronic hepatitis B viral infection remains one of the major medical problems in the world
and is a leading cause of morbidity and mortality. Advances in the treatment and prevention …

Results of the effectiveness and safety of leukocyte interferon (IFN-α 3n (Alfaferone®, Alfa
Wassermann) in 36 patients with chronic hepatitis C, including 9 patients with cirrhosis and …

Isaacs and Lindemann, in England, first characterised interferon (IFN) in 1957 and coined
the word to signify a protein, elaborated by virus-infected cells, that functions to prevent their …

* Corresponding. tuthor. Tel.: 39-75-5735432; Fax: 39-75-5783444. update the data
reported there paying particular attention to molecular pathogenesis and therapy. Important …

Stimulate the phagocytes. Drugs are a delusion. Find the germ of the disease; prepare from
it a suitable antitoxin; inject it three times a day, a quarter of an hour before meals and what …

Size: 0.5 mg Concentration: 1.0 mg/ml Clone: 7N4-1 Immunogen: Human IFN-α2b Isotype:
Mouse IgG1, κ Reactivity: QC Testing: Human Storage Buffer: No azide/low endotoxin …